Temasek widens India bets as portfolio swells to $42 billion

“On average, we deployed approximately $3 billion each year and we see ample opportunity to continue to do so,” he said, detailing that the bulk of the capital invested in FY26 is in subsequent opportunities. The investment firm has made follow-on investments in companies such as CureFit Healthcare, Cartrade, Manipal, Cloudnine and Licious in the past.